Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

Podobne zapisy

• A single-institution comparison of cetuximab, carboplatin, and paclitaxel induction chemotherapy followed by chemoradiation (CRT) versus CRT for locally-advanced squamous cell carcinoma of the head and neck (LA-SCCHN)
  od: Grover, Surbhi, i wsp.
  Wydane: (2016)
• Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)
  od: Wanebo, H. J., i wsp.
  Wydane: (2014)
• Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
  od: Haddad, R.I., i wsp.
  Wydane: (2019)
• Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  od: FUSHIMI, CHIHIRO, i wsp.
  Wydane: (2020)
• Efficacy and Safety of Paclitaxel Combined With Cetuximab for Head and Neck Squamous Cell Carcinoma
  od: OKADA, TAKURO, i wsp.
  Wydane: (2021)